Futrue GmbH Launches Delisting Offer for PharmaSGP Holding SE

Futrue GmbH has announced a plan to initiate a public delisting tender offer for PharmaSGP Holding SE's shares. The company aims to acquire all outstanding no-par value bearer shares with a cash consideration of EUR 28.00 per share, exceeding the recent six-month average share price. The bid is not subject to any closing conditions, ensuring a straightforward process for shareholders.

The agreement includes a delisting from the Frankfurt Stock Exchange's regulated market, supported by a planned extraordinary general meeting later in 2025 to facilitate the process. With a current holding of approximately 82.09% in PharmaSGP, Futrue GmbH intends to complete a squeeze-out of minority shareholders.

Shareholders are advised to review the offer document for detailed terms once available, as it will incorporate crucial information pertinent to the proposed offer and subsequent actions.